These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35498539)

  • 1. Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.
    Xu Y; Peng Y; Shen M; Liu L; Lei J; Gao S; Wang Y; Lan A; Li H; Liu S
    J Oncol; 2022; 2022():1525245. PubMed ID: 35498539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.
    Xu Y; Shu D; Shen M; Wu Q; Peng Y; Liu L; Tang Z; Gao S; Wang Y; Liu S
    J Immunol Res; 2022; 2022():9412119. PubMed ID: 35692496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
    Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
    Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
    Ren H; Shen X; Xie M; Guo X
    Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
    Sun Y; Xu Y; Che X; Wu G
    Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
    Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
    Front Genet; 2022; 13():834731. PubMed ID: 35432482
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Angiogenesis-Related Prognostic Biomarkers Associated With Immune Cell Infiltration in Breast Cancer.
    Tao D; Wang Y; Zhang X; Wang C; Yang D; Chen J; Long Y; Jiang Y; Zhou X; Zhang N
    Front Cell Dev Biol; 2022; 10():853324. PubMed ID: 35602610
    [No Abstract]   [Full Text] [Related]  

  • 10. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer.
    Qin M; Ma Y; Wang Z; Fang D; Wei J
    Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer.
    Chen J; Li X; Yan S; Li J; Zhou Y; Wu M; Ding J; Yang J; Yuan Y; Zhu Y; Wu W
    Front Oncol; 2022; 12():929240. PubMed ID: 36591508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification and prognostic evaluation of breast cancer subtypes defined by obesity-associated genes.
    Chen D; Xie Z; Yang J; Zhang T; Xiong Q; Yi C; Jiang S
    Discov Oncol; 2024 Apr; 15(1):133. PubMed ID: 38676834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
    Wang Z; Wang F
    Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing a novel prognostic signature of tumor driver genes for breast cancer.
    Zhou L; Yi Y; Liu C; Chen Z
    Am J Transl Res; 2022; 14(7):4515-4531. PubMed ID: 35958490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
    Zhang D; Duan Y; Cun J; Yang Q
    Front Genet; 2019; 10():278. PubMed ID: 30984247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.